Welcome to the fall edition of Oncology and Hematology Review, which features a wealth of topical and practical content for oncologists and hematologists, as well as being of interest to the wider medical community.
Our expert interviews continue to be popular, providing concise snapshots of hot topics in medicine. Among the expert interviews in this issue, Ian Flinn highlights the exciting recent developments that are improving outcomes in patients with B-cell malignancies, Wadie Bahou describes the role of platelets in cancer progression and metastasis, as well as their potential role as biomarkers, and Stephen Chun highlights the disparities in access to combined chemotherapy and radiotherapy for patients with small cell lung cancer across the US.
We also feature a review article by Das and Gibson on recent advances in metastatic esophageal and gastroesophageal junction adenocarcinoma. The incidence of these devastating malignancies is rising in the US, and treatment is challenging, but new therapeutic options are improving outcomes. The incidence of hepatocellular carcinoma also continues to increase. In another review, Chen, Lopez, and Vaccaro describe the current approach to the diagnosis, staging, and management of this condition, with a focus on evolving approaches to systemic treatment. Oncology and Hematology Review would like to thank all expert authors who contributed towards this edition.
A special thanks goes to our Editorial Board for their continuing support and guidance. Thanks also go to all organizations and media partners for their ongoing support. We hope that all our readers will find plenty of interest among these timely and thought-provoking articles.